GlassScriptPhysician profile
Melissa M Becker
NPI 1174514087
$5,318.86
in general payments reported to CMS, 2019-2025
43 companies · $1,196 in 2025
The $1,196 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $354 · 2021: $651 · 2022: $644 · 2023: $1,046 · 2024: $984 · 2025: $1,196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,225.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,137.40 | 2021-2025 | Ubrelvy, Vraylar |
| Lilly USA, LLC | $648.01 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $623.88 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Amgen INC. | $378.12 | 2019-2025 | Otezla, Repatha, Repatha |
| Glaxosmithkline, LLC. | $272.95 | 2019-2024 | Trelegy Ellipta |
| Novo Nordisk INC | $208.53 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $200.99 | 2019-2025 | Spravato |
| Pfizer INC. | $197.69 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $136.81 | 2019-2024 | Trintellix |
| Teleflex LLC | $115.95 | 2025 | Urolift |
| Bayer Healthcare Pharmaceuticals INC. | $108.54 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $106.69 | 2019-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.63 | 2020-2025 | Jardiance, Ofev |
| Channel Medsystems, INC. | $95.88 | 2023 | |
| Amarin Pharma, INC. | $83.80 | 2019-2020 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.